3[2]Jerums G,Auen TJ,Canmpell DJ,et al.Long-term comparison between perimdopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminutia.Am J Kidney Dis,2001,37 (5):890-899.
4DOMINGUEZ J H, TANG Nianjun, XU Wei, et al. Studies of renal injury Ⅲ:lipid-induced nephropathy in type Ⅱdiabetes [J]. Kidney Int, 2000,57(1):92-104.
5BHATT D L, TOPOL E J. Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease[J]. Med Clin North Am, 2000,84(1):163-179.
6ZHANG J J, WANG M, SHE Y B. Experimental research of antithrombus and ameliorantion of microcirculation of ginkgo biloba[J]. Chin J Integr Tradit West Med, 1995,15(5):320-323.
7KOYA D, LEE I K, ISHII H, et al. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol[J]. J Am Soc Nephrol, 1997,8(3):426-435.
8Steinberg HO,Paradisi G,Cronin J,et al. Type Ⅱ diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation, 2000,101 : 2040-2046.
1Navarro JF,Milena FJ,Mora C,et al.Renal pro-inf Lammatory cytokine gene expression in diabetic nephropathy:effect of angiotensin-converting enzyme inhibition and pentoxifylline administration[J].Am J Nephrol,2006,26(6):562-570.
2Cho EH,Kim EH,Kim WG,et al.Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes[J].Korean Diabetes,2010,34(3):200-206.
